Dr. Richard Stefanacci Dr. Richard Stefanacci

Richard G. Stefanacci, DO, MGH, MBA, AGSF, CMD is Chief Medical Officer at The Access Group. Dr. Stefanacci is a recognized thought-leader in healthcare reform. In addition, he leads the Government Policy Systems team, which ensures pharmaceutical products and diagnostic devices gain appropriate access and utilization.

Trump’s Love/Hate Relationship with Pharma

President Trump’s love/hate relationship with pharma will undoubtedly affect the care of my patients ...

Dr. Richard Stefanacci
Dr. Richard Stefanacci

Pharmaceutical Control is Shifting Again—Now it’s Health Systems in Charge!

My medical career has moved in line with the shift in prescription control. As ...

Dr. Richard Stefanacci
Dr. Richard Stefanacci

A Win-Win for Pharma

Among the latest organizational attempts to provide Medicare patients with access to high-quality, cost-effective ...

Dr. Richard Stefanacci
Dr. Richard Stefanacci
Donald Ohioma
Donald Ohioma

Big Pharma Beware: Medicare Changes to Long Term Care Will Impact All Markets

Even if you are not focused on the significant long-term care (LTC) market, the ...

Dr. Richard Stefanacci
Dr. Richard Stefanacci
Anwar Feroz, MSc
Anwar Feroz, MSc

CMS’ OCM: A New Bundle of Joy…or Something Else?

The Centers for Medicare & Medicaid Services (CMS) recently announced a bundled payment initiative ...

Dr. Richard Stefanacci
Dr. Richard Stefanacci

The Truth About ACOs

Pharma needs to understand the who, what and how of Accountable Care Organizations (ACOs) ...

Dr. Richard Stefanacci
Dr. Richard Stefanacci

Nursing Homes: A Very Unique Pharmaceutical Channel

Nursing homes are increasingly being held responsible for identifying conditions and addressing them through ...

Dr. Richard Stefanacci
Dr. Richard Stefanacci
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call